RejectionGrowth Factors in Allograft T Reject Islet Allografts: A Role for Novel IL-2 and IL-4 Double Knockout Mice
暂无分享,去创建一个
Terry B. Strom | Martin S. Zand | Yongsheng Li | P W Nickerson | J Steiger | Thomas R. Malek | Roberto Ceratti Manfro | Xin Xiao | Xian Chang | Prabir Roy-Chaudhury | Wayne W. Hancock | P. Nickerson | M. Zand | T. Strom | R. Manfro | Yongsheng Li | X. Zheng | T. Malek | J. Steiger | W. Hancock | Xianlin Chang | P. Roy-Chaudhury | Xian Chang
[1] B. Konieczny,et al. Heart allografts in murine systems. The differential activation of Th2-like effector cells in peripheral tolerance. , 1992, Transplantation.
[2] P. Linsley,et al. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2 , 1995, The Journal of experimental medicine.
[3] M. Jenkins,et al. The role of cell division in the induction of clonal anergy. , 1992, Immunology today.
[4] K. Rajewsky,et al. Development and proliferation of lymphocytes in mice deficient for both interleukins‐2 and ‐4 , 1994, European journal of immunology.
[5] T. Strom,et al. Distribution of IL-15 receptor alpha-chains on human peripheral blood mononuclear cells and effect of immunosuppressive drugs on receptor expression. , 1996, Journal of immunology.
[6] N. Sarvetnick,et al. IL-4 expression by grafts from transgenic mice fails to prevent allograft rejection. , 1997, Journal of immunology.
[7] P. Nickerson,et al. Prolonged islet allograft acceptance in the absence of interleukin 4 expression. , 1996, Transplant immunology.
[8] J. Renauld,et al. Thymic lymphomas in interleukin 9 transgenic mice. , 1994, Oncogene.
[9] W. Leonard,et al. The common gamma-chain of cytokine receptors regulates intrathymic T cell development at multiple stages. , 1997, Journal of immunology.
[10] K. Rajewsky,et al. Generation and analysis of interleukin-4 deficient mice. , 1991, Science.
[11] A. Fischer,et al. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[12] P. Nickerson,et al. IL-2 knockout recipient mice reject islet cell allografts. , 1995, Journal of immunology.
[13] R. Simmons,et al. Maturation of cytotoxic T cells within sponge matrix allografts. , 1983, Journal of immunology.
[14] M. Brach,et al. Interleukin 9 is expressed by primary and cultured Hodgkin and Reed-Sternberg cells. , 1992, Cancer research.
[15] H. Weiner,et al. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E. , 1995, The American journal of pathology.
[16] J. Renauld,et al. Human T cell lines and clones respond to IL-9. , 1993, Journal of immunology.
[17] P. Nickerson,et al. The Th1/Th2 paradigm and the allograft response. , 1996, Current opinion in immunology.
[18] F. Alt,et al. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. , 1995, Immunity.
[19] P. Linsley,et al. Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4. , 1997, Journal of immunology.
[20] W. Leonard,et al. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans , 1993, Cell.
[21] H. Griesser,et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. , 1995, Science.
[22] H. Volk,et al. Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients. , 1997, Journal of immunology.
[23] T. Strom,et al. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[24] T. Waldmann,et al. IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. , 1996, Immunity.
[25] B. Hall,et al. Cells mediating allograft rejection. , 1991, Immunological reviews.
[26] E. Shevach,et al. Interleukin 7 is a T-cell growth factor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[27] E. Field,et al. Prevention of Th1 response is critical for tolerance. , 1996, Transplantation.
[28] J. Snick,et al. Tcgfiii/p40 is produced by naive murine cd4+ t cells but is not a general t cell growth factor* , 1989 .
[29] N. Tanaka,et al. The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID. , 1996, Annual review of immunology.
[30] I. Horak,et al. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting , 1991, Nature.
[31] N. Sigal,et al. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. , 1990, Journal of immunology.
[32] M. Dallman,et al. Cytokines and their receptors in transplantation. , 1991, Current opinion in immunology.